Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion type Assertion NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_head.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion description "[The interleukin-3 receptor ? chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_provenance.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion evidence source_evidence_literature NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_provenance.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion SIO_000772 24030378 NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_provenance.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion wasDerivedFrom befree-2016 NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_provenance.
- NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_assertion wasGeneratedBy ECO_0000203 NP1109984.RAXfpHe_tkFmMmVrt3vHvDWjKmdqh7CqdyTWNC1ezU3-o130_provenance.